Publication, Part of National Diabetes Audit: Non-Diabetic Hyperglycaemia, Diabetes Prevention Programme
Non-Diabetic Hyperglycaemia, 2021-22, Diabetes Prevention Programme, Overview
Changes to NDA reporting
NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.
To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the ‘Related links' section of this page.
3 June 2024 00:00 AM
Summary
The NHS Diabetes Prevention Programme (DPP) is a joint commitment from NHS England, Office for Health Improvement and Disparities (OHID, formerly Public Health England) and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia (NDH).
Highlights
Highlights of the 2021-22 Annual Report
This report is an overview or State of the Nation report on the 2021-22 Non-Diabetic Hyperglycaemia audit.
The detailed analysis supporting this report can be found here:
Non-Diabetic Hyperglycaemia, 2021-22, Diabetes Prevention Programme, Detailed Analysis
Introduction
This is the 2021-22 annual State of the Nation report on people with non-diabetic hyperglycaemia (NDH) in England. It covers diagnosis of NDH, routine care of people with NDH and referrals to the NHS Diabetes Prevention Programme (NHS DPP).
People with NDH are at high risk of progressing to type 2 diabetes. NDH is diagnosed if blood glucose levels are above normal (HbA1c above 41 mmol/mol) but below the threshold for diabetes (HbA1c 48 mmol/mol). It is sometimes referred to as prediabetes. NICE recommends that everyone with NDH should have a weight check to measure Body Mass Index (BMI) and a blood test every year. This will help to quickly identify people who have gone on to develop type 2 diabetes.
- NICE Guidance: PH38: Type 2 diabetes: prevention in people at high risk
The NHS Diabetes Prevention Programme (DPP) launched in 2016 and became available throughout England in 2018. It is an evidence-based1 behaviour change programme where people are supported to maintain a healthy weight and be more active. DPP also aims to improve nutrition. These changes to lifestyle can prevent or delay the onset of type 2 diabetes.
This National Diabetes Audit report uses data from English general practice (GP) systems for 2021-22 and data from the NHS DPP programme providers for referrals from January 2021 up to the end of March 2022.
The National Diabetes Audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). HQIP is led by a consortium of the Academy of Medical Royal Colleges, the Royal College of Nursing, and National Voices. Its aim is to promote quality improvement in patient outcomes, and in particular, to increase the impact that clinical audit, outcome review programmes and registries have on healthcare quality in England and Wales. HQIP holds the contract to commission, manage, and develop the National Clinical Audit and Patient Outcomes Programme (NCAPOP), comprising around 40 projects covering care provided to people with a wide range of medical, surgical and mental health conditions. The programme is funded by NHS England, the Welsh Government and, with some individual projects, other devolved administrations and crown dependencies www.hqip.org.uk/national-programmes.
NDA data is available for all work streams2. Improvement methodologies have been advocated since 2016/173, 4. Presently the NDA is supporting application of these principles via Quality Improvement Collaboratives. We recommend that ICBs advocate and support use of these approaches to improving overall achievements and reducing variation.
References:
1. See the 2022 NHS Diabetes Prevention Programme National Service Specification
Last edited: 3 June 2024 10:19 am